Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHOICE HOTELS INTERNATIONAL INC /DECHH · Entity 3980 | Director | July 15, 2026 | July 17, 2026 |
| Monte Rosa Therapeutics, Inc.GLUE · Entity 4828 | 10% owner | June 28, 2021 | June 30, 2021 |
| NeueHealth, Inc.BHG · Entity 74308 | 10% owner | October 17, 2022 | October 19, 2022 |
| Savara IncSVRA · Entity 4900 | 10% owner | March 15, 2021 | March 16, 2021 |
| Veritiv CorpVRTV · Entity 107723 | Director | April 25, 2018 | April 26, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHOICE HOTELS INTERNATIONAL INC /DE
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,173.29 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 21 · Balance 16,173.29 F1: Weighted average price, as these shares were purchased in multiple transactions at prices ranging from $105.86 to $106.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Weighted average price, as these shares were purchased in multiple transactions at prices ranging from $105.86 to $106.69, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Monte Rosa Therapeutics, Inc.
Report date June 28, 2021 · Filed June 30, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Note 2 | 7,692,298 |
Last balance in matching sequence
After 2021-06-28 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2021-06-28 · Conversion · Acquired 2,715,968 · Balance 2,715,968 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Row 2 · 2021-06-28 · Conversion · Acquired 3,257,328 · Balance 5,973,296 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Row 3 · 2021-06-28 · Conversion · Acquired 669,002 · Balance 6,642,298 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Row 4 · 2021-06-28 · Purchase · Acquired 1,050,000 · Balance 7,692,298 F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. |
| Series A-2 convertible preferred stockSEC Table II · derivative / convertible security | IndirectSee Note 2 | 0 |
Reported balance
After 2021-06-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-06-28 · Conversion · Disposed 9,588,725 · Balance 0 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. |
| Series B convertible preferred stockSEC Table II · derivative / convertible security | IndirectSee Note 2 | 0 |
Reported balance
After 2021-06-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-06-28 · Conversion · Disposed 11,500,000 · Balance 0 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. |
| Series C convertible preferred StockSEC Table II · derivative / convertible security | IndirectSee Note 2 | 0 |
Reported balance
After 2021-06-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-06-28 · Conversion · Disposed 2,361,912 · Balance 0 F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date.
F2: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
NeueHealth, Inc.
Report date October 17, 2022 · Filed October 19, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series B Convertible Perpetual Preferred StockSEC Table II · derivative / convertible security | IndirectSee Note 4 | 37,700 |
Reported balance
After 2022-10-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-10-17 · Purchase · Acquired 37,700 · Balance 37,700 F1: The Issuer's Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") is convertible at the option of the holder (subject to the expiration or early termination of the applicable waiting period, if any, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended) into the number of shares of the Issuer's common stock ("Common Stock") equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 plus increases for accumulated quarterly dividends that are not paid in cash ("compounded dividends")) plus (ii) the accrued dividends with respect to each share of Series B Preferred Stock as of the applicable conversion date divided by (b) the conversion price as of the applicable conversion date (initially approximately $1.4169), subject to anti-dilution adjustments. F2: The Series B Preferred Stock has no expiration date. At any time after the third anniversary of the original issuance date, if the closing price per share of Common Stock is greater than 287% of the then applicable conversion price (initially $4.07) for (x) at least 20 trading days in any period of 30 consecutive trading days and (y) the last trading day immediately before the Issuer provides notice of its election to convert, the Issuer may elect to convert all of the Series B Preferred Stock into the relevant number of shares of Common Stock. [Continued on Note 3] F3: [Continuation of Note 2] At any time following the fifth anniversary of the original issuance date, the Issuer may redeem all of the Series B Preferred Stock for a per share amount in cash equal to: (i) the sum of (A) the liquidation preference (reflecting increases for compounded dividends) thereof plus (B) all accrued dividends as of the applicable redemption date, multiplied by (ii) (A) 105% if the redemption occurs at any time prior to the seventh anniversary of the original issuance date and (B) 100% if the redemption occurs at any time on or after the seventh anniversary of the original issuance date. F4: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. |
| Series B Convertible Perpetual Preferred StockSEC Table II · derivative / convertible security | IndirectSee Note 5 | 100,000 |
Reported balance
After 2022-10-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-10-17 · Purchase · Acquired 100,000 · Balance 100,000 F1: The Issuer's Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") is convertible at the option of the holder (subject to the expiration or early termination of the applicable waiting period, if any, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended) into the number of shares of the Issuer's common stock ("Common Stock") equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 plus increases for accumulated quarterly dividends that are not paid in cash ("compounded dividends")) plus (ii) the accrued dividends with respect to each share of Series B Preferred Stock as of the applicable conversion date divided by (b) the conversion price as of the applicable conversion date (initially approximately $1.4169), subject to anti-dilution adjustments. F2: The Series B Preferred Stock has no expiration date. At any time after the third anniversary of the original issuance date, if the closing price per share of Common Stock is greater than 287% of the then applicable conversion price (initially $4.07) for (x) at least 20 trading days in any period of 30 consecutive trading days and (y) the last trading day immediately before the Issuer provides notice of its election to convert, the Issuer may elect to convert all of the Series B Preferred Stock into the relevant number of shares of Common Stock. [Continued on Note 3] F3: [Continuation of Note 2] At any time following the fifth anniversary of the original issuance date, the Issuer may redeem all of the Series B Preferred Stock for a per share amount in cash equal to: (i) the sum of (A) the liquidation preference (reflecting increases for compounded dividends) thereof plus (B) all accrued dividends as of the applicable redemption date, multiplied by (ii) (A) 105% if the redemption occurs at any time prior to the seventh anniversary of the original issuance date and (B) 100% if the redemption occurs at any time on or after the seventh anniversary of the original issuance date. F5: The Reporting Person is a manager of NEA 18 VGE GP, LLC, which is the sole general partner of NEA Partners 18 VGE, L.P. ("NEA Partners 18 VGE"). NEA Partners 18 VGE is the sole general partner of NEA 18 Venture Growth Equity, L.P. ("NEA 18 VGE"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 18 VGE in which the Reporting Person has no pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: The Issuer's Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") is convertible at the option of the holder (subject to the expiration or early termination of the applicable waiting period, if any, under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended) into the number of shares of the Issuer's common stock ("Common Stock") equal to the quotient of (a) the sum of (i) the liquidation preference (initially $1,000 plus increases for accumulated quarterly dividends that are not paid in cash ("compounded dividends")) plus (ii) the accrued dividends with respect to each share of Series B Preferred Stock as of the applicable conversion date divided by (b) the conversion price as of the applicable conversion date (initially approximately $1.4169), subject to anti-dilution adjustments.
F2: The Series B Preferred Stock has no expiration date. At any time after the third anniversary of the original issuance date, if the closing price per share of Common Stock is greater than 287% of the then applicable conversion price (initially $4.07) for (x) at least 20 trading days in any period of 30 consecutive trading days and (y) the last trading day immediately before the Issuer provides notice of its election to convert, the Issuer may elect to convert all of the Series B Preferred Stock into the relevant number of shares of Common Stock. [Continued on Note 3]
F3: [Continuation of Note 2] At any time following the fifth anniversary of the original issuance date, the Issuer may redeem all of the Series B Preferred Stock for a per share amount in cash equal to: (i) the sum of (A) the liquidation preference (reflecting increases for compounded dividends) thereof plus (B) all accrued dividends as of the applicable redemption date, multiplied by (ii) (A) 105% if the redemption occurs at any time prior to the seventh anniversary of the original issuance date and (B) 100% if the redemption occurs at any time on or after the seventh anniversary of the original issuance date.
F4: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
F5: The Reporting Person is a manager of NEA 18 VGE GP, LLC, which is the sole general partner of NEA Partners 18 VGE, L.P. ("NEA Partners 18 VGE"). NEA Partners 18 VGE is the sole general partner of NEA 18 Venture Growth Equity, L.P. ("NEA 18 VGE"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 18 VGE in which the Reporting Person has no pecuniary interest.
Savara Inc
Report date March 15, 2021 · Filed March 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Note 1 | 24,137,931 |
Reported balance
Holding disclosure · report date 2021-03-15 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 24,137,931 F1: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"). NEA 17 is the sole member of Growth Equity Opportunities 17, LLC ("GEO 17"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the GEO 17 shares in which the Reporting Person has no pecuniary interest. |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"). NEA 17 is the sole member of Growth Equity Opportunities 17, LLC ("GEO 17"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the GEO 17 shares in which the Reporting Person has no pecuniary interest.
Veritiv Corp
Report date April 25, 2018 · Filed April 26, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 6,827 |
Reported balance
After 2018-04-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-04-25 · Grant · Acquired 3,674 · Balance 6,827 F1: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock.
F2: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Squarespace, Inc.
Report date October 17, 2024 · Filed October 17, 2024
Section 16 reporting ended · disclosed 2024-10-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2024-10-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-10-17 · Disposition to issuer · Disposed 6,197 · Balance 0 F1: Pursuant to the Amended and Restated Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 9, 2024, by and among the Issuer, Spaceship Purchaser, Inc. ("Parent") and Spaceship Group MergerCo Inc., a wholly owned subsidiary of Parent, immediately prior to the effective time of the Merger (as defined in the Merger Agreement), each Issuer restricted stock unit ("RSU") award held by a non-employee of the Issuer then outstanding and not vested was cancelled and converted into the right to receive a lump sum cash payment equal to the product of (i) $46.50 per share, without interest, multiplied by (ii) the number of shares of Class A Common Stock of the Issuer subject to such RSU award, prorated based on the number of days between the grant date and the closing of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Amended and Restated Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 9, 2024, by and among the Issuer, Spaceship Purchaser, Inc. ("Parent") and Spaceship Group MergerCo Inc., a wholly owned subsidiary of Parent, immediately prior to the effective time of the Merger (as defined in the Merger Agreement), each Issuer restricted stock unit ("RSU") award held by a non-employee of the Issuer then outstanding and not vested was cancelled and converted into the right to receive a lump sum cash payment equal to the product of (i) $46.50 per share, without interest, multiplied by (ii) the number of shares of Class A Common Stock of the Issuer subject to such RSU award, prorated based on the number of days between the grant date and the closing of the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 16, 2021 Filed Jul 19, 2021 18:37 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 8.28 | $117.00 | $968.76 |
DisclosureSEC source: 0001209191-21-047113 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,385.6 F1 · price: Average price reflects a series of transactions between $116.77 and $117.07. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 17:02 UTC | Squarespace, Inc. SQSP · Entity 86709 | Exercise / conversionRestricted Stock Units · Derivative | 6,084 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-088312 · tm2121244d3_4.xml · derivative · entry 2 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,084 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The restricted stock units vested on June 30, 2021. F1 · derivative.expiration_date: The restricted stock units vested on June 30, 2021. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 17:02 UTC | Squarespace, Inc. SQSP · Entity 86709 | Exercise / conversionClass A Common Stock | 6,084 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-088312 · tm2121244d3_4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,670 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionSeries C convertible preferred Stock · Derivative | 2,361,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · derivative · entry 7 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 0 Underlying: Common Stock · 669,002 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionSeries B convertible preferred stock · Derivative | 11,500,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · derivative · entry 6 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 0 Underlying: Common Stock · 3,257,328 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionSeries A-2 convertible preferred stock · Derivative | 9,588,725 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · derivative · entry 5 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 0 Underlying: Common Stock · 2,715,968 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.exercise_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F1 · derivative.expiration_date: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | PurchaseCommon Stock | 1,050,000 | $19.00 | $19,950,000.00 |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · nonDerivative · entry 4 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 7,692,298 F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionCommon Stock | 669,002 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · nonDerivative · entry 3 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 6,642,298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionCommon Stock | 3,257,328 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · nonDerivative · entry 2 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 5,973,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 28, 2021 Filed Jun 30, 2021 22:04 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | ConversionCommon Stock | 2,715,968 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-044041 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 2 Disclosed balance after: 2,715,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A-2 convertible preferred stock, Series B convertible preferred stock and Series C convertible preferred stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock on a one-for-3.5305 basis upon the closing of the Issuer's initial public offering without payment or additional consideration. The Preferred Stock had no expiration date. F2 · ownership.nature: The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 10, 2021 Filed Jun 14, 2021 20:09 UTC | Squarespace, Inc. SQSP · Entity 86709 | GrantRestricted Stock Units · Derivative | 4,300 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-080975 · tm2119727-3_4seq1.xml · derivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300 Underlying: Class A Common Stock · 4,300 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest on June 10, 2022, subject to continued service through the vesting date. F1 · derivative.expiration_date: The restricted stock units will vest on June 10, 2022, subject to continued service through the vesting date. Read SEC document |
| May 24, 2021 Filed May 25, 2021 17:21 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 841 | $118.82 | $99,927.62 |
DisclosureSEC source: 0001209191-21-035640 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,377.3 F1 · price: Weighted average price, as these shares were purchased in multiple transactions at prices ranging from $118.43 to $119.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 21, 2021 Filed May 21, 2021 18:13 UTC | Squarespace, Inc. SQSP · Entity 86709 | GiftClass A Common Stock | 3,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-070591 · tm2117248d3_4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,586 F1 · kind: The reporting person transferred these shares as a gift. Read SEC document |
| May 07, 2021 Filed May 10, 2021 16:38 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1,215 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031168 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,536.3 F1 · kind: Restricted stock will vest in three annual installments beginning on the first anniversary of the grant date. Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 14:27 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 762 | $106.49 | $81,145.38 |
DisclosureSEC source: 0001209191-21-018835 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,321.3 F1 · price: Average price reflects a series of transactions between $106.10 and $106.86. Read SEC document |
| February 24, 2021 Filed Feb 25, 2021 15:47 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | SaleCommon Stock | 2,932 | $109.55 | $321,200.60 |
DisclosureSEC source: 0001209191-21-014170 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,559.3 F1 · price: Average price reflects a series of transactions between $109.55 and $109.57. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:22 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-026882 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,491.3 F1 · kind: Restricted stock will vest in three annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 16, 2020 Filed Apr 17, 2020 16:07 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 4.02 | $69.73 | $280.31 |
DisclosureSEC source: 0001209191-20-024737 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,349.3 F1 · price: Average price reflects a series of transactions between $69.59 and $70.14. Read SEC document |
| January 16, 2020 Filed Feb 26, 2020 00:04 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 2.78 | $100.47 | $279.31 |
DisclosureSEC source: 0001209191-20-012760 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,345.3 F1 · price: Average price reflects a series of transactions between $99.63 and $101.03. Read SEC document |
| October 16, 2019 Filed Oct 17, 2019 18:41 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 3 | $88.75 | $266.25 |
DisclosureSEC source: 0001209191-19-053380 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,342.5 F1 · price: Average price reflects a series of transactions between $87.97 and $89.18. Read SEC document |
| July 17, 2019 Filed Jul 18, 2019 19:53 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 2.97 | $89.59 | $266.08 |
DisclosureSEC source: 0001209191-19-042611 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,339.5 F1 · price: Average price reflects a series of transactions between $89.56 and $89.90. Read SEC document |
| April 19, 2019 Filed Apr 22, 2019 16:39 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1,715 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-025432 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,336.5 F1 · kind: Restricted stock will vest in three annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 17, 2019 Filed Apr 17, 2019 16:37 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.85 | $80.94 | $149.74 |
DisclosureSEC source: 0001209191-19-024894 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,621.5 F1 · price: Average price reflects a series of transactions between $80.85 and $80.99. Read SEC document |
| January 17, 2019 Filed Jan 17, 2019 17:46 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.98 | $75.56 | $149.61 |
DisclosureSEC source: 0001209191-19-004115 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,619.7 F1 · price: Average price reflects a series of transactions between $75.50 and $75.63. Read SEC document |
| October 16, 2018 Filed Oct 18, 2018 20:11 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.93 | $75.49 | $145.70 |
DisclosureSEC source: 0001209191-18-055528 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,617.7 F1 · price: Average price reflects a series of transactions between $75.37 and $75.52. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 19:04 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.93 | $77.25 | $149.09 |
DisclosureSEC source: 0001209191-18-042808 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,615.8 F1 · price: Average price reflects a series of transactions between $77.18 and $77.30. Read SEC document |
| April 25, 2018 Filed Apr 26, 2018 17:34 UTC | Veritiv Corp VRTV · Entity 107723 | GrantPhantom Stock · Derivative | 3,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-18-000700 · primary_01.xml · derivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,827 Underlying: Common Stock · 3,674 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2 · derivative.exercise_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. F2 · derivative.expiration_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 18:08 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-025806 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,613.9 F1 · kind: Restricted stock will vest in three annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 17, 2018 Filed Apr 19, 2018 18:15 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.84 | $80.76 | $148.60 |
DisclosureSEC source: 0001209191-18-025531 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,005.9 Read SEC document |
| January 17, 2018 Filed Jan 19, 2018 17:06 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 1.83 | $80.76 | $147.79 |
DisclosureSEC source: 0001209191-18-004464 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,004 F1 · price: Average price reflects a series of transactions between $80.70 and $80.90. Read SEC document |
| October 20, 2017 Filed Oct 20, 2017 17:42 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 2 | $67.68 | $135.36 |
DisclosureSEC source: 0001209191-17-057549 · doc4.xml · nonDerivative · entry 2 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,002.2 Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 17:42 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 2.18 | $67.63 | $147.43 |
DisclosureSEC source: 0001209191-17-057549 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000.2 Read SEC document |
| May 25, 2017 Filed May 25, 2017 17:56 UTC | Veritiv Corp VRTV · Entity 107723 | GrantPhantom Stock · Derivative | 3,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-17-000737 · primary_01.xml · derivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,153 Underlying: Common Stock · 3,153 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of Veritiv Corporation common stock. F2 · derivative.exercise_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. F2 · derivative.expiration_date: Shares of phantom stock are fully vested and non-forfeitable on the grant date and shall be paid to the reporting person in shares of Veritiv Corporation common stock on the elected distribution date under the Veritiv Corporation Deferred Compensation Savings Plan. Read SEC document |
| May 15, 2017 Filed May 16, 2017 18:47 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 684 | $62.39 | $42,674.76 |
DisclosureSEC source: 0001209191-17-032580 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,998 F1 · price: Average price reflects a series of transactions between $62.35 and $62.45 Read SEC document |
| April 21, 2017 Filed Apr 24, 2017 17:04 UTC | CHOICE HOTELS INTERNATIONAL INC /DE CHH · Entity 3980 | GrantCommon Stock | 2,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-027946 · doc4.xml · nonDerivative · entry 1 Landsman Liza · CIK 0001624108 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,314 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.